• Journal of Ginseng Research
• /
• 제20권3호
• /
• pp.241-247
• /
• 1996

The effects of ginseng total saponin, ginsenoside-Rb, and -Rb, on the reduction of chmlesterol level and the myNA expression rates of HMG CoA reductase and LDL receptor in Hep G2 were investigated and compared with that of lovastatin, a competitive HMG CoA reductase Inhibitor. The amounts of cholesterol in Hep G2 decreased in total saponin-and ginsenoside-treated groups as compared with that of control group, while there was no significant reduction in lovastatin-treated group. The mRNA expression rates of HMG CoA reductase increased in total saponin and gin- senoside groups except for ginsenoside-Rb, (10-3%) group and decreased in lovastatin group com- pared with that of control group. The mRNA expression rates of LDL receptor generally increased In all of the test groups except for total saponin (10-5%) group compared with that of control group. Because the ginseng components tested were more effective in the reduction of cholesterol level in Hep G2 than lovastatin and induced the gene expression of LDL receptor, we suggest the possibility that they could be used as a replacement agent for lovastatin which can not be prescribed especially to patients with hepatic diseases.

• Applied Biological Chemistry
• /
• 제36권4호
• /
• pp.260-264
• /
• 1993

인삼을 조미제품의 첨가성분으로 이용할 때 그 NaCl 농도에서 인삼성분의 안정성을 규명하기 위하여, 미삼과 홍삼정을 NaCl 농도별로 처리하여 pH, 색상 및 ginsenosides 함량을 조사한 결과, 미삼의 경우 NaCl 농도가 증가 할수록 pH는 높아졌으나 홍삼정 시험구에서는 유의적인 변화가 없었다. 색상은 NaCl 농도가 증가 될수록 감소하였다. n-BuOH extract 수율은 5% NaCl 농도에서 감소하였고 그 이상의 농도에서는 증가하는 경향을 나타내었으며, 증감 범위는 홍삼정이 컸다. Ginsenosides 함량은 diol계 saponin인 ginsenoside-Re, $-Rb_1$, $-Rb_2$, -Rc, -Rd 및 triol계 saponin인 ginsenoside-Re 모두 5% NaCl 농도에서 감소하였고 그 이상의 농도에서 증가하는 경향이었으며, 특히 ginsenoside-Re가 가장 민감한 증감의 변화를 보였다.

• 생약학회지
• /
• 제26권4호
• /
• pp.360-367
• /
• 1995

The metabolism of ginseng saponins by human intestinal bacteria was studied using human feces under anaerobic culture conditions. $Ginsenoside-Rb_1$, $-Rb_2$ and -Rc(protopanaxadiol type) were mainly metabolized to compound-K(C-K), $20-O-[{\alpha}-L-arabinopyranosyl(1{\rightarrow}6)-{\beta}-{_D}-glucopyranosyl]-20(S)-protopanaxadiol(compound-Y,\;C-Y)$, $20-O-[{\alpha}-L-arabinopyranosyl(1{\rightarrow}6)-{\beta}-{_D}-glucopyranosyll-20(S)-protopanaxadiol(ginsenosied-MC,{\;}MC)$, respectively, and $ginsenoside-Rg_1$ and -Re(protopanaxatriol type) to their aglycon, 20(S)-protopanaxatriol, though the pathway and rate of the metabolism were affected by fermentation medium. C-K was not decomposed any more, while C-Y and Mc were both gradually hydrolyzed to C-K.